Results
10
Companies which are more than 50% undervalued based on analyst price target.
10 companies
Kolon TissueGene
Market Cap: ₩3.9t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩46,750.00
7D
-7.8%
1Y
234.9%
Hugel
Market Cap: ₩3.2t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩297,500.00
7D
-3.1%
1Y
23.2%
Daewoong Pharmaceutical
Market Cap: ₩1.6t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩136,500.00
7D
-0.9%
1Y
0.7%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩129,300.00
7D
-6.2%
1Y
-11.3%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩24,750.00
7D
-5.0%
1Y
3.3%
Medy-Tox
Market Cap: ₩838.1b
Operates as a biopharmaceutical company in South Korea.
A086900
₩119,400.00
7D
-3.5%
1Y
-35.6%
BINEX
Market Cap: ₩509.9b
Operates as a pharmaceutical company in South Korea.
A053030
₩16,010.00
7D
-7.6%
1Y
-32.6%
Dong-A ST
Market Cap: ₩414.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩45,300.00
7D
-4.8%
1Y
-34.1%
Korea United Pharm
Market Cap: ₩276.9b
Engages in the manufacture and sale of pharmaceutical products in South Korea.
A033270
₩18,820.00
7D
-4.7%
1Y
-8.9%
Macrogen
Market Cap: ₩165.8b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,290.00
7D
-2.2%
1Y
-11.9%